U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SARS-COV-2 CN2 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
M1QXB372B8
Investigational
General
Names
6
Identifiers
2
Related Substances
1
SARS-COV-2 CN2 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
M1QXB372B8
Investigational
General
Approval Year
Unknown
149,124
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CORONAVAC
Preferred Name
English
SARS-COV-2 CN2 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
Common Name
English
PICOVACC
Brand Name
English
INACTIVATED COVID-19 CN2 STRAIN VACCINE ANTIGEN
Common Name
English
PICOVACC ANTIGEN
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
2
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
M1QXB372B8
PRIMARY
SMS_ID
300000028454
PRIMARY
Showing 1 to 2 of 2 entries
Previous
1
Next
Related Substances
1
ACTIVE MOIETY
M1QXB372B8
SARS-COV-2 CN2 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN